AstraZeneca Pharma India
-
Karnataka signs MoU with AstraZeneca Pharma India
To deploy AI based lung cancer screening technology that will screen a patient for 29 lung diseases in one chest…
Read More » -
AstraZeneca receives CDSCO approval for Tremelimumab combination in India
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC) AstraZeneca Pharma India…
Read More » -
AstraZeneca’s Dapagliflozin tabs get DCGI nod
The drug will be used for patients with chronic kidney disease AstraZeneca Pharma India has received approval from the Drugs…
Read More »